+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 14Years - 50Years
FEMALE
ID05245695

Evaluating EndoCheck Deep Neural Network for Diagnosing Endometriosis in Women with Chronic Pelvic Pain

Led by Aspira Women's Health · Updated on 2026-10-28

1200

Participants Needed

10

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the clinical validity of EndoCheck, a deep neural network algorithm that detects protein biomarkers for diagnosing endometriosis in women with chronic pelvic pain. The study aims to compare EndoChecks performance to laparoscopic surgical assessment to determine its usefulness as an aid in diagnosis. This observational study focuses on sensitivity and specificity to assess the tests accuracy. Participants will not receive any intervention as this is an observational study. The study seeks to optimize EndoCheck to achieve at least 94% sensitivity and 79% specificity. Secondary goals include evaluating the tests performance based on pain severity and other clinical factors in the participants. Participants will undergo laparotomy or laparoscopy procedures as part of their clinical care, and researchers will collect data to compare with EndoCheck test results. The study will monitor sensitivity and specificity over 24 months. Participants will provide informed consent and be assessed for eligibility. The overall study duration extends up to the primary completion date in November 2026.

CONDITIONS

Brief Title

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

Research Team

M

Marla Then, CRC

S

Silvana Franco

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here